22V-21730-70425
4 vaccinations
0 coded responses
13 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 292 / SC
- Registered
- 2021-10-08
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-29
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Dose 2 — Pfizer-BioNTech
-
2021-10-08
Registered in v-safe
-
2021-10-08
Dose 3 — Pfizer-BioNTech
-
2022-10-25
Dose 4 — Pfizer-BioNTech
- 2022-10-25
-
2022-10-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-27
- 2022-10-28
- 2022-10-30
- 2022-10-31
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-24
- 2022-11-29
- 2022-12-06
- 2023-01-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-29 | Pfizer-BioNTech | No |
| 2 | 2021-01-21 | Pfizer-BioNTech | No |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
| 4 | 2022-10-25 | Pfizer-BioNTech | No |
Free text
None.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.